Neurocognitive Disorders Research
To inquire about your eligibility to enroll in one of the below clinical trials, please contact:
Karyn Korash 713-486-0523 or Omar Hasan 713-486-0524
Investigating a Transmissible Component of Dementia
The purpose of this research study is to collect data regarding potential associations between Alzheimer disease and potential sources of transmission, such as surgery history, blood transfusion, or meat consumption.
Development of a Novel Biochemical Diagnostic Technique for Alzheimer Disease
The primary purpose of this study to determine whether a protein found in the blood is present at different levels in patients with Alzheimer disease (AD) compared to individuals without the disease. A secondary aim of this study is to identify the effects of adding human amyloid-beta into mouse models of AD.
Genetic Screening of Cases with Frontotemporal Dementia (FTD)
The purpose of this research study is to study the deoxyribonucleic acid (DNA) of individuals with frontotemporal dementia (FTD), a medical condition that leads to loss of brain tissue. In this study, we will attempt to identify the type(s) of mutations in an attempt to better understand the disease process.
Epigenetic Changes Underlying Alzheimer’s Disease
This study is investigating epigenetic changes in people who may have, or be at risk for, Alzheimer’s disease. In this study, we will attempt to create an epigenetic profile of patients and their caretakers who come to the Neurocognitive Disorders Center. The aim is to better outline, at an earlier stage, the differences between those who have Alzheimer’s disease and those who do not.